Status:
UNKNOWN
The Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System
Lead Sponsor:
Shandong University
Conditions:
Early Gastric Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to valuation of the diagnostic ability of white light imaging and magnifying endoscopy with optical enhancement system in early gastric cancer and intraepithelial neoplasi...
Detailed Description
Stomach cancer is the second most common cause of cancer death. Endoscopic identification and treatment of gastric intestinal metaplasia (GIM) and early gastric cancer (EGC) is essential to improve pa...
Eligibility Criteria
Inclusion
- Patients aged 18-80 years with H. pylori infection or histologically verified gastric lesions (chronic atrophic gastritis, intestinal metaplasia, GIN or EGC)
- Or patients aged 40-80 years from a region with high incidence of gastric cancer
- Or patients aged 40-80 years with first-degree relative of patients with gastric cancer
- Or patients aged 40-80 years with high-risk factors for gastric cancer (high salt or pickle diet or smoking or heavy drinking)
Exclusion
- A history of gastrectomy
- Active gastrointestinal bleeding or advanced gastric carcinoma
- Coagulopathy or severe underlying diseases
- Pregnancy or lactation
- Absence of informed consent
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04411589
Start Date
May 1 2020
End Date
May 1 2022
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012